ebixa
h. lundbeck a/s - memantinhydroklorid - alzheimers sykdom - andre anti-demens medisiner - behandling av pasienter med moderat til alvorlig alzheimers sykdom.
ebixa 5 mg/0.5 ml
2care4 aps - memantinhydroklorid - mikstur, oppløsning - 5 mg/0.5 ml
ebixa 20 mg
orifarm as - memantinhydroklorid - tablett, filmdrasjert - 20 mg
ebixa 10 mg
farmagon - memantinhydroklorid - tablett, filmdrasjert - 10 mg
ebixa 10 mg
orifarm as - memantinhydroklorid - tablett, filmdrasjert - 10 mg
plerixafor accord
accord healthcare s.l.u. - plerixafor - multiple myeloma; hematopoietic stem cell transplantation - immunostimulants, - adult patientsplerixafor accord is indicated in combination with granulocyte-colony stimulating factor (g-csf) to enhance mobilisation of haematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in adult patients with lymphoma or multiple myeloma whose cells mobilise poorly (see section 4. paediatric patients (1 to less than 18 years)plerixafor accord is indicated in combination with g-csf to enhance mobilisation of haematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in children with lymphoma or solid malignant tumours, either:- pre-emptively, when circulating stem cell count on the predicted day of collection after adequate mobilization with g-csf (with or without chemotherapy) is expected to be insufficient with regards to desired hematopoietic stem cells yield, or- who previously failed to collect sufficient haematopoietic stem cells (see section 4.
bicalutamide bluefish 50 mg
bluefish pharmaceuticals ab - bikalutamid - tablett, filmdrasjert - 50 mg
bicalutamide bluefish 150 mg
bluefish pharmaceuticals ab - bikalutamid - tablett, filmdrasjert - 150 mg
bicalutamide teva 50 mg
teva sweden ab - bikalutamid - tablett, filmdrasjert - 50 mg
bicalutamide teva 150 mg
teva sweden ab - bikalutamid - tablett, filmdrasjert - 150 mg